Your browser doesn't support javascript.
loading
PD-L1 copy number gain in nonsmall-cell lung cancer defines a new subset of patients for anti PD-L1 therapy.
Goldmann, T; Kugler, C; Reinmuth, N; Vollmer, E; Reck, M.
Affiliation
  • Goldmann T; Research Center Borstel, Borstel Airway Research Center North (ARCN), Member of the German Center for Lung Research, Großhansdorf tgoldmann@fz-borstel.de.
  • Kugler C; LungenClinic Grosshansdorf, Großhansdorf, Germany.
  • Reinmuth N; Airway Research Center North (ARCN), Member of the German Center for Lung Research, Großhansdorf LungenClinic Grosshansdorf, Großhansdorf, Germany.
  • Vollmer E; Research Center Borstel, Borstel.
  • Reck M; Airway Research Center North (ARCN), Member of the German Center for Lung Research, Großhansdorf LungenClinic Grosshansdorf, Großhansdorf, Germany.
Ann Oncol ; 27(1): 206-7, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26487587

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / B7-H1 Antigen / Lung Neoplasms / Antineoplastic Agents Limits: Female / Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / B7-H1 Antigen / Lung Neoplasms / Antineoplastic Agents Limits: Female / Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article